FDA Bans Pharmacy Owner from Compounding Sterile Drugs

Article

Paul W. Franck allegedly manufactured and distributed products that violated the Federal Food, Drug, and Cosmetic Act.

The FDA has entered a permanent injunction against Paul W. Franck, who allegedly manufactured and distributed products that violated the Federal Food, Drug, and Cosmetic Act (FD&C Act).

Franck, of Ocala, Florida, may not manufacture, hold, or distribute sterile drugs until he complies with the FD&C Act and other requirements.

“Mr. Franck risked the health of the American public by compounding drugs under unacceptable conditions,” said Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, in a press release. “[This] action reflects the FDA’s continued efforts to take appropriate and aggressive enforcement action against those who put patients’ health at risk by choosing not to follow the law.”

Franck owned and operated several compounding pharmacies, such as Franck’s Compounding Lab and Trinity Care Solutions, for more than 20 years.

FDA investigations found several issues with Franck’s businesses:

  • His drugs contained “filthy, putrid, or decomposed substances.”
  • The products were produced or held in unsanitary conditions and were below quality and/or purity standards.
  • Some of the labels were false or misleading, since purportedly sterile drugs actually contained bacterial contamination.

In 2014, Trinity Care Solutions had recalled all sterile drugs and ceased compounding operations after an FDA inspection found dead spiders, beetles, ants, wasps, and cockroaches in the ceiling panel above the sterile processing area. In addition, the compounding facility was not cleaning and sanitizing sterile compounding areas.

In 2012, contaminated ophthalmic drugs, compounded at Franck’s Compounding Lab, led to 47 cases of eye infections, including around 39 cases of temporary or permanent vision loss.

Also, 21 polo ponies died in 2009 after taking a product compounded by Franck’s Compounding Lab that contained 100 times the amount of selenium that should have been administered.

Related Videos
male pharmacist using digital tablet during inventory in pharmacy | Image Credit: sofiko14 - stock.adobe.com
Pharmacist holding medicine box in pharmacy drugstore. | Image Credit: I Viewfinder - stock.adobe.com
Pharmacy Drugstore Checkout Cashier Counter | Image Credit: Gorodenkoff - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Capsules medicine and white medicine bottles on table | Image Credit: Satawat - stock.adobe.com
Human cell or Embryonic stem cell microscope background | Image Credit: Anusorn - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
Biosimilar pharmaceutical drug bottle on blue background. | Image Credit: Carl - stock.adobe.com
Pharmaceutical manufacture background with glass bottles with clear liquid on automatic conveyor line. | Image Credit: wacomka - stock.adobe.com
Bottle and scattered pills on color background, top view | Image Credit: New Africa - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.